Novigenix AI
PrivateLast Round
Grant
Mar 31, 2025
Total Funding Raised
$25.99M
Company Overview
Novigenix AI is a Swiss precision medicine company developing immuno-transcriptomic solutions for early cancer detection, therapy optimization, and disease monitoring.
Sector
Healthcare & Life Sciences
Verticals
Precision Medicine, Medical AI, Clinical Trials, Drug Discovery, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Novigenix AI Comps
Public and private peers based on sector, stage, and business model.
Novigenix AI Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Mar 31, 2025 | ||||
| Grant | Sep 24, 2024 | ||||
| Series B | Nov 15, 2022 | ||||
| Grant | Dec 22, 2020 | ||||
| Grant | Jan 21, 2020 | ||||
Series A Extension | Jan 18, 2011 |
Key People
Founding team and executive leadership
Novigenix AI Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Initiative Capital Romandie | Series A Extension |
| Innovative Health Initiative | Grant |
| Maastricht University | Grant |
| NeoMed Management | Series A Extension |
| Eurostars SME programme | Grant |
| KU Leuven | Grant |
| Radboud University | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 2, 2025
Monthly visitors grew 54% from 1.3K to 2K.
- Mar 31, 2025
$1.94M grant from the Innovative Health Initiative.
Novigenix AI Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Novigenix AI's valuation, stock price, and market status.
